Transient left ventricular apical ballooning syndrome (Takotsubo cardiomyopathy) following orthotopic liver transplantation
Howard R. Lee, R. Todd Hurst, Hugo E. Vargas – 30 August 2007
Malaria infection through multiorgan donation: An update from Spain
Monserrat Rodriguez, Santiago Tome, Luis Vizcaino, Javier Fernandez‐Castroagudin, Esteban Otero‐Anton, Esther Molina, Jorge Martinez, Gloria De la Rosa, Jose Lovo, Evaristo Varo – 30 August 2007 – During the last years, immigration has increased and, consequently, the pool of foreign donors and associated infectious diseases from exotic countries (especially from the tropics) has also increased. Only a few cases of malaria transmitted via different donation sources have been published. In the present report, a Plasmodium vivax transmitted through a multiorgan donation is reported.
Application of intraoperative cine‐portogram to detect spontaneous portosystemic collaterals missed by intraoperative doppler exam in adult living donor liver transplantation
Deok‐Bog Moon, Sung‐Gyu Lee, ChulSoo Ahn, Shin Hwang, Ki‐Hun Kim, TaeYong Ha, GiWon Song, JeHo Ryu, KyuBo Sung, GiYoung Ko – 30 August 2007 – Adequate portal inflow is essential to the regeneration of a partial liver graft after adult living donor liver transplantation (LDLT).
Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
Phunchai Charatcharoenwitthaya, Sylvania Pimentel, Jayant A. Talwalkar, Felicity T. Enders, Keith D. Lindor, Ruud A.F. Krom, Russell H. Wiesner – 30 August 2007 – The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long‐term follow‐up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known.
How, why, and when does primary biliary cirrhosis recur after liver transplantation?
- Read more about How, why, and when does primary biliary cirrhosis recur after liver transplantation?
Roger Williams, M. Eric Gershwin – 30 August 2007
Predicting outcome in acute liver failure: Are we there yet?
Gerry MacQuillan – 30 August 2007
Successful long‐term repair of hepatic artery pseudoaneurysm following liver transplantation with primary stent‐grafting
Georg Elias, Cristiana Rastellini, Hannan Nsier, Pradeep Nazarey, Melissa Brown, Mohan Pahari, Lawton Shick, Ducksoo Kim, Luca Cicalese – 30 August 2007
Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis
Dimitrios N. Samonakis, Evangelos Cholongitas, Ulrich Thalheimer, George Kalambokis, Alberto Quaglia, Christos K. Triantos, Maria Mela, Penelope Manousou, Marco Senzolo, Amar Paul Dhillon, David Patch, Andrew Kenneth Burroughs – 30 August 2007 – Progression of fibrosis following recurrent hepatitis C virus (HCV) infection is frequent after liver transplantation (LT). Histology remains the gold standard to assess fibrosis, but the value of hepatic venous pressure gradient (HVPG) is being explored.
Impact of non‐congestive graft size in living donor liver transplantation: New indicator for additional vein reconstruction in right liver graft
Hideya Kamei, Yasuhiro Fujimoto, Shunji Nagai, Ryuichiro Suda, Hidekazu Yamamoto, Tetsuya Kiuchi – 30 August 2007 – Addition of the middle hepatic vein (MHV) or reconstruction of its tributaries to increase noncongestive graft volume is expected to improve graft function in right liver living donor liver transplantation (LDLT). However, the relationship between noncongestive graft volume and graft function after transplantation has not been clarified and definitive criteria for the reconstruction of MHV tributaries have yet to be established. We analyzed 29 right liver LDLT cases.
Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans
Hiroto Egawa, Shingi Uemoto, Yasutugu Takada, Kazue Ozawa, Satoshi Teramukai, Hironori Haga, Mureo Kasahara, Kouhei Ogawa, Hiroshi Sato, Masako Ono, Kenji Takai, Masanori Fukushima, Kayo Inaba, Koichi Tanaka – 30 August 2007 – We have found that steroid bolus withdrawal prior to graft reperfusion increased the incidence of acute cellular rejection (ACR). This study aims to clarify how initial steroid bolus (ISB) injection at reperfusion influences the kinetics of CD8+ alloreactive immune responses immediately after living donor liver transplantation (LDLT).